Dioscorea polystachya Turcz. Extract attenuates osteoclastogenesis and ovariecto...

연구 요약

Dioscorea polystachya Turcz. Extract attenuates osteoclastogenesis and ovariectomy-induced bone loss in rats.

Journal of ethnopharmacology 학술지에 발표된 이 연구는 Lee J, Choi Y, Hwang Y 외 연구팀이 수행하였습니다.

이 연구는 'Dioscorea polystachya Turcz. Extract attenuates osteoclastogenesis and ovariectomy-induced bone loss in rats.'에 대한 과학적 분석을 제공합니다.

핵심 내용

ETHNOPHARMACOLOGICAL RELEVANCE: Dioscorea polystachya Turcz. has been traditionally used in East Asian herbal medicine to strengthen bones and treat musculoskeletal conditions. However, the pharmacological mechanisms underlying its anti-osteoporotic effects remain poorly defined. AIM OF THE STUDY: This study aimed to investigate the anti-osteoporotic potential of D. polystachya root extract (DRE) through its effects on osteoclast differentiation and function, using both in vitro and in vivo models. MATERIALS AND METHODS: Osteoclastogenesis was induced in bone marrow-derived macrophages (BMMs) by stimulation with receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), and the effects of DRE on osteoclast formation were assessed by tartrate-resistant acid phosphatase (TRAP) staining and qRT-PCR analysis of key osteoclastogenic genes (e.g., Nfatc1, c-Fos, Ctsk, Mmp9, Acp5). For in vivo analysis, ovariectomized (OVX) rats were orally administered DRE for eight weeks. Micro-computed tomography (micro-CT), histological staining (H&E and IHC for cathepsin K), and serum biomarker assays such as alkaline phosphatase (ALP) and TRAP were used to evaluate trabecular bone preservation and osteoclast activity. RESULTS: DRE significantly inhibited osteoclast formation and suppressed the expression of osteoclast-related transcription factors and functional markers in vitro. In OVX rats, DRE treatment dose-dependently attenuated trabecular bone loss, reduced serum ALP and TRAP levels, and preserved trabecular architecture. IHC analysis showed a marked reduction in cathepsin K-positive cells in the DRE-treated group compared to OVX controls. CONCLUSIONS: DRE exerts anti-osteoporotic effects by suppressing osteoclast differentiation and activity, thereby mitigating bone loss in estrogen-deficient conditions. These findings highlight the potential of D. polystachya as a promising natural therapeutic agent for the prevention and treatment of postmenopausal osteoporosis.

일반인을 위한 해석

구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.

실천 사항

• 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
• 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
• 이상 반응이 나타나면 즉시 전문가에게 문의하세요

의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41173080)